Interactions Between Total Nucleated and CD34 Cell Dose and Their Impact on Outcomes After Single and Double Unrelated Cord Blood Transplantation for Patients with Hematological Malignancies. An Analysis on Behalf of Societe' Francaise De Greffe De Moelle Et Therapie Cellulaire (SFGM-TC) and Eurocord

被引:0
|
作者
Michallet, Mauricette [1 ]
Cunha, Renato L. G. [2 ]
Michel, Gerard [3 ]
Socie, Gerard [2 ]
Mohty, Mohamad [4 ]
Rio, Bernard [5 ]
Blaise, Didier [6 ]
Sirvent, Anne [7 ]
Tabrizzi, Reza [8 ]
Bordigoni, Pierre [9 ]
Deconinck, Eric [10 ]
Yakoubagha, Ibrahim [11 ]
Rossi, Jean-Francois [12 ,13 ]
Maillard, Natacha [14 ]
Sobh, Mohamad [1 ]
Garnier, Federico [15 ]
Ruggeri, Annalisa [2 ]
Gluckman, Eliane [2 ]
Rocha, Vanderson [2 ]
机构
[1] Hop Edouard Herriot, Lyon, France
[2] Hop St Louis, Paris, France
[3] Hop La Timone, Dept Hematol, Marseille, France
[4] CHU Nantes, Dept Hematol, F-44035 Nantes 01, France
[5] Hop Hotel Dieu, Paris, France
[6] Inst J Paoli I Calmettes, F-13009 Marseille, France
[7] Hop Archet I, Hematol Clin, Nice, France
[8] Hop Haut Leveque, Pessac, France
[9] Hop Brabois, Hop Enfants, Nancy, France
[10] French Belgian Swiss APL Grp, Bobigny, France
[11] Hop Claude Huriez, Serv Hematol, Lille, France
[12] CHU Montpellier, Montpellier, France
[13] INSERM, U847, Montpellier, France
[14] CHU Poitiers, Poitiers CIC 802, INSERM, Paris, France
[15] Agence Biomed, Paris, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:163 / 164
页数:2
相关论文
共 50 条
  • [1] Impact of total nucleated (TNC) and CD34+cell dose on different outcomes after double unrelated cord blood transplantation in patients with haematological malignancies. An analysis on behalf of the SFGM-TC and Eurocord
    Michallet, M.
    Cunha, R.
    Michel, G.
    Socie, G.
    Mohty, M.
    Rio, B.
    Blaise, D.
    Sirvent, A.
    Bordigoni, P.
    Deconinck, E.
    Yakoub-Agha, I.
    Rossi, J. -F.
    Maillard, N.
    Tabrizi, R.
    Ruggeri, A.
    Sobh, M.
    Gluckman, E.
    Milpied, N.
    Rocha, V.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S12 - S12
  • [2] UPDATED ANALYSIS OF ALLOGENEIC HSCT AFTER RIC FOR HEMATOLOGICAL MALIGNANCIES FROM THE SOCIETE FRANCAISE DE GREFFE DE MOELLE OSSEUSE ET DE THERAPIE CELLULAIRE (SFGM-TC) REGISTRY
    Michallet, M.
    Michallet, M.
    Le, Q.
    Mohty, M.
    Sobh, M.
    Nicolini, F. E.
    Boiron, J. -M.
    Esperou, H.
    Attal, M.
    Milpied, N.
    Lioure, B.
    Bordigoni, P.
    Yackoub-Agha, I.
    Bourhis, J.
    Rio, B.
    Deconninck, E.
    Renaud, M.
    Raus, N.
    Blaise, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 166 - 166
  • [3] Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)
    Robin, Marie
    Tabrizi, Reza
    Mohty, Mohamad
    Furst, Sabine
    Michallet, Mauricette
    Bay, Jacques-Olivier
    Cahn, Jean-Yves
    De Coninck, Eric
    Dhedin, Nathalie
    Bernard, Marc
    Rio, Bernard
    Buzyn, Agnes
    Huynh, Anne
    Bilger, Karin
    Bordigoni, Pierre
    Contentin, Nathalie
    Porcher, Raphael
    Socie, Gerard
    Milpied, Noel
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 152 (03) : 331 - 339
  • [4] Hematopoietic Stem Cell Transplantation in Multiple Myeloma: A Retrospective Study of the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)
    Beaussant, Yvan
    Daguindau, Etienne
    Pugin, Aurore
    Mohty, Mohamad
    Avet-Loiseau, Herve
    Roos-Weil, Damien
    Michallet, Mauricette
    Chevalier, Patrice
    Raus, Nicole
    El-Cheikh, Jean
    Tabrizi, Reza
    Huyn, Anne
    Buzyn, Agnes
    Socie, Gerard
    Vincent, Laure
    Guilhot, Francois
    Yakoub-Agha, Ibrahim
    Lenain, Pascal
    Francois, Sylvie
    Beckerich, Florence
    Lioure, Bruno
    Bulabois, Claude-Eric
    Deconinck, Eric
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (08) : 1452 - 1459
  • [5] Updated analysis of allogeneic HSCT after RIC for hematological malignancies from the Societe Francaise de Greffe de Moelle Osseuse et de Therapie Cellulaire (SFGM-TC) registry.
    Michallet, Mauricette
    Le, Quoc-Hung
    Mohty, Mohamad
    Nicolini, Franck E.
    Boiron, Jean-Michel
    Esprou, Helene
    Attal, Michel
    Milpied, Noel
    Lioure, Bernard
    Bordigoni, Pierre
    Yackoub-Agha, Ibrahim
    Bourhis, Jean-Henri
    Rio, Bernard
    Deconninck, Eric
    Renaud, Marc
    Sobh, Mohamad
    Raus, Nicole
    Blaise, Didier
    BLOOD, 2007, 110 (11) : 329A - 329A
  • [6] Impact of genetic abnormalities after allogeneic stem cell transplantation in multiple myeloma: report of the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)
    Weil, D. Roos
    Moreau, P.
    Avet-Loiseau, H.
    Kuentz, M.
    Milpied, N.
    Socie, G.
    Furst, S.
    Huynh, A.
    Vigouroux, S.
    Le Gouill, S.
    Thiebault, A.
    Buzyn, A.
    Cahn, J. -Y.
    Maillard, N.
    Yakoub-Agha, I.
    Soulier, J.
    Raus, N.
    Fermand, J. -P.
    Rio, B.
    Golmard, J. L.
    Attal, M.
    Blaise, D.
    Michallet, M.
    Dhedin, N.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S18 - S18
  • [7] Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)
    Chevallier, P.
    Labopin, M.
    Milpied, N.
    Bilger, K.
    Socie, G.
    Yakoub-Agha, I.
    Michallet, M.
    Bulabois, C-E
    Maury, S.
    Beguin, Y.
    Bay, J-O
    Blaise, D.
    Maillard, N.
    Guillerm, G.
    Daguindeau, E.
    Raus, N.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 (03) : 361 - 365
  • [8] Allogeneic HSCT after RIC: an updated analysis from the registry of the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)
    Michallet, M.
    Le, Q.
    Sobh, M.
    Mohty, M.
    Nicolini, F. E.
    Boiron, J.
    Esperou, H.
    Attal, M.
    Milpied, N.
    Lioure, B.
    Bordigoni, P.
    Yackoub-Agha, I.
    Bourhis, J.
    Rio, B.
    Deconninck, E.
    Renaud, M.
    Raus, N.
    Blaise, D.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S69 - S69
  • [9] EFFICACY OF ECULIZUMAB IN ALLOGENIC STEM CELL TRANSPLANTATION ASSOCIATED THROMBOTIC MICROANGIOPATHY: A RETROSPECTIVE STUDY ON BEHALF THE SOCIETE FRANCAISE DE GREFFE DE MOELLE ET DE THERAPIE CELLULAIRE (SFGM-TC)
    De Fontbrune, F. Sicre
    Galambrun, C.
    Sirvent, A.
    Huynh, A.
    Faguer, S.
    Quoc, S. Nguyen
    Bay, J. O.
    Neven, B.
    Moussi-Frances, J.
    Lioure, B.
    Xhaard, A.
    Fremeaux-Bacchi, V.
    Veyradier, A.
    Coppo, P.
    Socie, G.
    de latour, R. Peffault
    BONE MARROW TRANSPLANTATION, 2014, 49 : S31 - S31
  • [10] Reduced Intensity Conditioning Regimen Prior to Unrelated Cord Blood Transplantation In Patients with Acute Myeloid leukemia: Preliminary Analysis of a Prospective Phase II Multicentric Trial on Behalf of Societe Francaise De Greffe De Moelle Osseuse Et Therapie Cellulaire (SFGM-TC) and Eurocord
    Rio, Bernard
    Chevret, Sylvie
    Vigouroux, Stephane
    Chevallier, Patrice
    Furst, Sabine
    Sirvent, Anne
    Bay, Jacques-Olivier
    Socie, Gerard
    Ceballos, Patrice
    Huynh, Anne
    Cornillon, Jerome
    Francois, Sylvie
    Legrand, Faezeh
    Yakoub-Agha, Ibrahim
    Michel, Gerard
    Maillard, Natacha
    Margueritte, Genevieve
    Maury, Sebastien
    Uzunov, Madalina
    Bulabois, Claude Eric
    Michallet, Mauricette
    Clement, Laurence
    Dauriac, Charles
    Bilger, Karin
    Simon, Tabassome
    Gluckman, Eliane
    Milpied, Noel
    Rocha, Vanderson
    BLOOD, 2010, 116 (21) : 402 - 402